Differential c‐Fos immunoreactivity in arousal‐promoting cell groups following systemic administration of caffeine in rats
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Despite the widespread use of caffeine, the neuronal mechanisms underlying its stimulatory effects are not completely understood. By using c‐Fos immunohistochemistry as a marker of neuronal activation, we recently showed that stimulant doses of caffeine activate arousal‐promoting hypothalamic orexin (hypocretin) neurons. In the present study, we investigated whether other key neurons of the arousal system are also activated by caffeine, via dual immunostaining for c‐Fos and transmitter markers. Rats were administered three doses of caffeine or saline vehicle during the light phase. Caffeine at 10 and 30 mg/kg, i.p., increased motor activities, including locomotion, compared with after saline or a higher dose, 75 mg/kg. The three doses of caffeine induced distinct dose‐related patterns of c‐Fos immunoreactivity in several arousal‐promoting areas, including orexin neurons and adjacent neurons containing neither orexin nor melanin‐concentrating hormone; tuberomammillary histaminergic neurons; locus coeruleus noradrenergic neurons; noncholinergic basal forebrain neurons that do not contain parvalbumin; and nondopaminergic neurons in the ventral tegmental area. At any dose used, caffeine induced little or no c‐Fos expression in cholinergic neurons of the basal forebrain and mesopontine tegmentum; dopaminergic neurons of the ventral tegmental area, central gray, and substantia nigra pars compacta; and serotonergic neurons in the dorsal raphe nucleus. Saline controls exhibited only few c‐Fos‐positive cells in most of the cell groups examined. These results indicate that motor‐stimulatory doses of caffeine induce a remarkably restricted pattern of c‐Fos expression in the arousal‐promoting system and suggest that this specific neuronal activation may be involved in the behavioral arousal by caffeine. J. Comp. Neurol. 498:667–689, 2006. © 2006 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurons containing hypocretin (orexin) project to multiple neuronal systems
Peyron, C., Tighe, D. K., van den Pol, A. N., de Lecea, L., Heller, H. C., Sutcliffe, J. G., & Kilduff, T. S. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-23-09996.1998 · Cited by 3,466 · cited 1×
“The cell bodies stained with this antiorexin B antibody were discretely distributed in the PeF-LH as previously described using another orexin B antibody (Cutler et al., 1999) or an antipreprohypocretin precursor antibody (Peyron et al., 1998).”
MethodFredholm, B. B., Bättig, K., Holmén, J., Nehlig, A., & Zvartau, E. E. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01396-6 · Cited by 2,624 · cited 5×
“These doses are significantly below the median lethal dose, LD50, which is approximately 200 mg/kg in rat (Fredholm et al., 1999).”
BackgroundInfluentialSteinbusch, H. W. M. (1981) · Neuroscience · doi:10.1016/0306-4522(81)90146-9 · Cited by 2,415
Aston-Jones, G., & Bloom, F. (1981) · The Journal of Neuroscience · doi:10.1523/jneurosci.01-08-00876.1981 · Cited by 1,960
The use of c-fos as a metabolic marker in neuronal pathway tracing
Dragunow, M., & Faull, R. (1989) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(89)90150-7 · Cited by 1,416 · cited 1×
“…been very useful in identifying the transmitter phenotype of neurons activated in response to a variety of experimental conditions, but this strategy is not without limitations; one major drawback is that not all active neurons express c-Fos (Dragunow and Faull, 1989; Deurveilher and Semba, 2006).”
BackgroundA role for lateral hypothalamic orexin neurons in reward seeking
Harris, G. C., Wimmer, M., & Aston-Jones, G. (2005) · Nature · doi:10.1038/nature04071 · Cited by 1,311 · cited 1×
“In contrast, treatments that elicited consummatory or drug-seeking behaviors were associated with greater c-Fos expression in laterally localized orexin neurons (Baldo et al., 2004; Harris et al., 2005).”
ResultActivation of ventrolateral preoptic neurons during sleep
Sherin, J. E., Shiromani, P. J., McCarley, R. W., & Saper, C. B. (1996) · Science · doi:10.1126/science.271.5246.216 · Cited by 1,111
Fos Expression in Orexin Neurons Varies with Behavioral State
Estabrooke, I. V., McCarthy, M. T., Ko, E., Chou, T. C., Chemelli, R. M., Yanagisawa, M., Saper, C. B., & Scammell, T. E. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-05-01656.2001 · Cited by 654
Adenosine A2A, but not A1, receptors mediate the arousal effect of caffeine
Huang, Z.-L., Qu, W.-M., Eguchi, N., Chen, J.-F., Schwarzschild, M. A., Fredholm, B. B., Urade, Y., & Hayaishi, O. (2005) · Nature Neuroscience · doi:10.1038/nn1491 · Cited by 640
Caffeine Induces Dopamine and Glutamate Release in the Shell of the Nucleus Accumbens
Solinas, M., Ferré, S., You, Z.-B., Karcz-Kubicha, M., Popoli, P., & Goldberg, S. R. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-15-06321.2002 · Cited by 338 · cited 2×
“To support this postulation, caffeine can increase dopamine and glutamate levels in the striatum via blockade of inhibitory presynaptic A1 receptors (Okada et al., 1996; Solinas et al., 2002; Quarta et al., 2004).”
BackgroundLéna, I., Parrot, S., Deschaux, O., Muffat‐Joly, S., Sauvinet, V., Renaud, B., Suaud‐Chagny, M. ‐., & Gottesmann, C. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20602 · Cited by 322
Gallopin, T., Luppi, P.-H., Cauli, B., Urade, Y., Rossier, J., Hayaishi, O., Lambolez, B., & Fort, P. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.05.045 · Cited by 229 · cited 1×
“Caffeine may also inhibit the activation of sleep-promoting neurons in the ventrolateral preoptic nucleus (VLPO) by blocking presynaptic, presumably A1 receptors on inhibitory inputs (Chamberlin et al., 2003; Morairty et al., 2004) or postsynaptic A2A receptors (Gallopin et al., 2005).”
BackgroundKarcz-Kubicha, M., Antoniou, K., Terasmaa, A., Quarta, D., Solinas, M., Justinova, Z., Pezzola, A., Reggio, R., Müller, C. E., Fuxe, K., et al. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300167 · Cited by 189
Maloney, K. J., Mainville, L., & Jones, B. E. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.01907.x · Cited by 122
Cited by
Samuels, E., & Szabadi, E. (2008) · Current Neuropharmacology · doi:10.2174/157015908785777193 · Cited by 454
Nicotine Decreases Food Intake Through Activation of POMC Neurons
Mineur, Y. S., Abizaid, A., Rao, Y., Salas, R., DiLeone, R. J., Gündisch, D., Diano, S., De Biasi, M., Horvath, T. L., Gao, X.-B., et al. (2011) · Science · doi:10.1126/science.1201889 · Cited by 439
Arousal Effect of Caffeine Depends on Adenosine A2A Receptors in the Shell of the Nucleus Accumbens
Lazarus, M., Shen, H.-Y., Cherasse, Y., Qu, W.-M., Huang, Z.-L., Bass, C. E., Winsky-Sommerer, R., Semba, K., Fredholm, B. B., Boison, D., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.6730-10.2011 · Cited by 327
“…and subcortical areas also directly or indirectly receive NAc shell outputs (Zahm and Heimer, 1993; Yoshida et al., 2006; Sano and Yokoi, 2007; Sesack and Grace, 2010) and produce strong c-Fos expression, a marker for neuronal activation, in response to systemic caffeine (Deurveilher et al., 2006).”
Self-citation
Metadata
- Authors
- Deurveilher, S., Lo, H., Murphy, J. A., Burns, J., & Semba, K.
- Venue
- Journal of Comparative Neurology
- Publisher
- Wiley
- Published
- 2006-08-17
- Volume
- 498
- Issue
- 5
- Pages
- 667-689
- ISSN
- 0021-9967 (ISSN-L)
- 1096-9861
- OpenAlex
- W2054554983
- Cited by
- 68
- References
- 14
- FWCI
- 2.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.